Physician profile
Scott V Perryman
NPI 1083800999
$2,185.40
in general payments reported to CMS, 2019-2025
9 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $29.71 · 2021: $436 · 2022: $31.31 · 2023: $293 · 2024: $584 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,400.34 | 2021-2025 | Signia, Sonicision, Ligasure |
| Covidien LP | $306.95 | 2019 | |
| Inspire Medical Systems, INC. | $163.21 | 2023-2025 | Inspire |
| Intuitive Surgical, INC. | $118.52 | 2025 | |
| Ethicon US, LLC | $54.01 | 2020-2023 | Enseal X1, Echelon Endopath |
| Intra-Sana Laboratories | $51.47 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Asensus Surgical, INC. | $47.22 | 2019 | |
| Braintree Laboratories, INC. | $25.81 | 2025 | Sutab |
| Merck Sharp & Dohme LLC | $17.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Perryman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.